Skip to main content
. 2022 Mar 30;13(4):8382–8395. doi: 10.1080/21655979.2022.2036891

Table 2.

Correlation is of miR-631 with clinicopathological features

Features Groups Cases MiR-631
P
The elevated
(n = 24)
The declined
(n = 24)
Age <60 15 7 8 0.7555
≥60 33 17 16
Gender Male 29 17 12 0.1400
Female 19 7 12
Tumor size (cm) ≥5 cm 38 15 23 0.0045
<5 cm 10 9 1
Histological grade Moderate 30 13 17 0.2330
Low 18 11 7
TNM staging I + II 22 14 8 0.0822
III + IV 26 10 16
Smoking history Smoking 35 17 18 0.7453
No smoking 13 7 6